Replies to post #29279 on EP Global Communications Inc fka EPGL

[vikingzskillz]

The MPDD has seen high demand in anticipation of it's 2013 release, EPGL has been accepting pre-orders onthe MPDD and continue to have great demand and interest building for the rollout in 2013. Also EPGL has sent a test marketing piece for the MPDD to approximately 5,000 Physicians. EPGL has had a tremendous response...... When the MPDD is rolled out, EPGL will be utilizing the services of a major distribution channel to be announced.

ALSO IN R&D

Biomedical, MicroElectroMechanical Systems (BioMems) will become a core focus for EPGL moving forward.

EPGL has focus on safer delivery of drugs, treatments and diagnosis, anywhere in the body via new BioMems devices under development.

EPGL owns unique IP and know-how in BioMems with several applications currently in development.

View all tweets here:

http://www.epglmed.com/EPGL_Medical_Sciences/Home.html